Transcatheter real-time MRI guided myocardial chemoablation using acetic acid
© Rogers et al. 2016
Published: 27 January 2016
In patients with ischemic cardiomyopathy, radiofrequency ablation for ventricular arrhythmias can have limited efficacy because of the mismatch between lesion depth and substrate thickness, and because radiofrequency-induced edema surrounding the lesion is reversible resulting in only temporary conduction block. We hypothesized that transcatheter needle injection under real-time magnetic resonance imaging (MRI) of caustic agents doped with gadolinium contrast could achieve deep targeted and irreversible myocardial ablation which could be assessed acutely.
Caustic agent (ethanol or acetic acid) was injected into the myocardium of 8 swine using MRI-conspicuous needle catheters incorporating loopless antennae for active visualization under real-time MRI. MRI and histological appearances of acute and chronic lesions were compared. An animal model of ischemic cardiomyopathy was created in 10 swine by sub-selective transcoronary ethanol administration into non-contiguous territories. The conductive isthmus between adjacent infarcts was targeted for chemoablation under direct real-time MRI guidance. Baseline and post-chemoablation electroanatomic mapping was performed under X-ray fluoroscopic guidance using a commercial system.
Real-time MRI guided myocardial chemoablation with acetic acid is feasible and enables fully transmural substrate-targeted ablation by real-time visualization of arrhythmic substrate and immediate depiction of irreversible ablation lesions. Acetic acid creates more circumscribed and homogeneous lesions than ethanol. Using this technique, we demonstrate anatomical ablation of a conductive isthmus by late gadolinium enhancement and functional abolition of abnormal electrograms in an animal model of ischemic cardiomyopathy. Real-time MRI guided chemoablation could improve efficacy of arrhythmic substrate ablation in the thick ventricular myocardium.
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.